Enteral Feeding Formulas Market Scope
Enteral Feeding Formulas are produced to meet the basic macro-and micronutrient requirements of individuals who cannot meet their nutrition. These formulas are orally consumed to exhibit pharmacologic properties, such as immune-enhancing formulas containing arginine, glutamine, nucleotides, and ω-3 fatty acids. As per a survey, of the total United States births, ~10% were preterm births in 2018. These formulas contain much more calcium, phosphorus, vitamins, and minerals than term formulas and support appropriate growth for the preterm infant after discharge. The rising cases of malnutrition and frailty among the geriatric population with comorbidities, such as stroke, depression, diabetes, and dementia have increased various disorders in humans mainly owing to various age-related changes in body composition and muscle mass. The rising use of enteral feeding formulas in infants and adults who unable to meet the nutrient requirements has driven the market growth.
According to AMA, the Global Enteral Feeding Formulas market is expected to see growth rate of 7.02%The global enteral feeding formulas market is fragmented and largely competitive due to the presence of several global and regional manufacturers. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant risk factors for the growth of manufacturers in the market. Research Analyst at AMA estimates that United States and European Players will contribute to the maximum growth of Global Enteral Feeding Formulas market throughout the predicted period.
Abbott Laboratories (United States), Nestlé S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi AG (Germany), Mead Johnson Nutrition Company (United States), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (United States), Victus Inc. (United States), Meiji Holdings Co., Ltd. (Japan), Global Health Product Inc. (United States), Trovita Health Science (United States), Nutritional Medicinals, LLC (United States) and Hangzhou Nutrition Biotechnology Co., Ltd. (China) are some of the key players that are part of study coverage.
Segmentation Overview
The study have segmented the market of Global Enteral Feeding Formulas market by Type (Standard Formulas {Polymeric Formulas, Monomeric Formulas} and Disease-specific Formulas {Diabetic Formulas, Renal Formulas, Hepatic Formulas, Pulmonary Formulas, Other}), by Application (Oncology, Gastroenterology, Neurology, Diabetes, Critical Care and Other Applications) and Region with country level break-up.
On the basis of geography, the market of Enteral Feeding Formulas has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Enteral Feeding Formulas Market Dynamics:
Attributes | Details |
---|
Growth Drivers | - Increased Therapeutic Uses Of Enteral Feeding Formula
- Growing Geriatric Population and Preterm Births
|
Influencing Trends | - Technological Advancement in Feeding Formulas
|
Restraints | - Complications Associated with Enteral Nutrition
|
Road Blocks / Challenges | - Patient Safety Risks and Occurrence of Feeding or Medication Errors
|
Gaps & Opportunities | - Growing Healthcare Expenditure Capacity in Emerging Economies
- Demand for Personalized Medicines
|
In June 2020, Otsuka Pharmaceutical Factory Inc. introduced ENORAS Liquid for enteral use in coffee and strawberry flavor. The product is a concentrated polymeric enteric nutrition formula to efficiently provide nutrients and energy in a small amount.
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Enteral Feeding Formulas Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End Users
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.